1
|
Sun XS, Le Guevelou J, Jacquemin J, Drouet Y, Sio TS, Bar-Sela G, Carrie C, Faivre JC, Khalifa J, Demiroz C, Qiu H, Schick U, Atalar B, Fakhry N, Mengue L, Pan J, Servagi-Vernat S, Thariat J. Impact of radiotherapy on survival in resected or unresectable anaplastic thyroid carcinomas, a Rare Cancer Network study. Cancer Radiother 2022; 26:717-723. [PMID: 35715353 DOI: 10.1016/j.canrad.2022.01.003] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/04/2021] [Revised: 01/04/2022] [Accepted: 01/14/2022] [Indexed: 11/15/2022]
Abstract
PURPOSE Anaplastic thyroid carcinomas (ATC) are a heterogenous group of tumors of overall dismal prognosis. We designed models to identify relevant prognostic factors of survival of irradiated ATC patients including radiotherapy modalities (field size, dose). MATERIAL AND METHODS Between 2000 and 2017, 166 ATC patients' treatments were divided into surgery and postoperative radiotherapy (poRT) or definitive radiotherapy (RT). Multiple imputation approach was used for missing data. Prognostic factors were identified using Lasso-penalized Cox modelling and predicted risk scores were built. RESULTS Patients undergoing RT (n=70) had more adverse patient and disease characteristics than those undergoing poRT (n=96). Corresponding median survival rates were 5.4 and 12.1 months, respectively. PoRT patients undergoing poRT more likely received extended-field radiotherapy with prophylactic nodal irradiation, but rather received platinum- vs. adriamycin-based chemoradiotherapy. Radiotherapy was conventionally fractionated, delivered >60Gy in 51.9% and 61.7% and used extended fields in 88.5% and 71.2% of patients with poRT or RT. Radiotherapy interruption rates for toxicity were similar in the two groups. The best poRT-group model identified age>45yo, PS≥1, pathologic tumor stage≥pT4b,>N1 and R2 resection as poor prognostic factors. The best RT-group model (C-index of 0.72) identified PS≥3,>N1 and extended-field radiotherapy with prophylactic nodal irradiation (as opposed to tumour-bed irradiation only) as poor prognostic factors. CONCLUSION In patients undergoing poRT, radiotherapy parameters had little influence over their survival irrespective of patient, disease characteristics, and quality of resection. In patients undergoing RT, extended-field radiotherapy improved survival in addition to PS and nodal stage.
Collapse
Affiliation(s)
- X S Sun
- Department of Radiation Therapy, University Hospital Besancon-Montbeliard, Montbeliard, France.
| | - J Le Guevelou
- Department of Radiation Oncology, Centre François Baclesse, Caen, France
| | - J Jacquemin
- Département Prévention et Santé Publique, Centre Léon Bérard, Lyon, France
| | - Y Drouet
- Département Prévention et Santé Publique, Centre Léon Bérard, Lyon, France
| | - T S Sio
- Department of Radiation Oncology, Mayo Clinic, Phoenix, Arizona, USA
| | - G Bar-Sela
- Department of Radiation Oncology, Rambam health Care Campus, Haifa, Israel
| | - C Carrie
- Department of Radiation Oncology, Centre Leon Berard, Lyon, France
| | - J-C Faivre
- Department of Radiation Oncology, Institut de Cancérologie de Lorraine, Nancy, France
| | - J Khalifa
- Department of Radiation Oncology, Oncopole, Toulouse, France
| | - C Demiroz
- Department of Radiation Oncology, Uludag University school of medicine, Bursa, Turkey
| | - H Qiu
- Department of Radiation Oncology, University Hospital, Limoges, France
| | - U Schick
- Department of Radiation Oncology, CHRU Brest, Brest, France
| | - B Atalar
- Department of Radiation Oncology, University Hospital Acibadem MAA University, School of Medicine, Istanbul, Turkey
| | - N Fakhry
- Department of Surgery, CHU La Conception, Marseille, France
| | - L Mengue
- Department of Radiation Therapy, University Hospital Besancon-Montbeliard, Montbeliard, France
| | - J Pan
- Department of Radiation Oncology, Fujian Province Tumor Hospital, Fuzhou, China
| | - S Servagi-Vernat
- Department of Radiation Oncology, Institut Jean Godinot, Reims, France
| | - J Thariat
- Department of Radiation Oncology, Centre François Baclesse, Caen, France
| |
Collapse
|
2
|
Antoine A, Pérol D, Gilberg M, Lasset C, Choquet R, Robain M, Yahia BBH, Drouet Y. Utilisation des données de vie réelle pour estimer l'effet traitement en cancérologie: émulation du protocole de l'essai randomisé E2100 à partir de la base nationale ESME. Rev Epidemiol Sante Publique 2022. [DOI: 10.1016/j.respe.2022.03.100] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
3
|
Drouet Y. A genome-wide association study (GWAS) of event-free survival in follicular lymphoma treated in first-line therapy with immunochemotherapy: study design and initial results using a leave-one-cohort-out cross-validation statistical approach. Rev Epidemiol Sante Publique 2022. [DOI: 10.1016/j.respe.2022.03.018] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
4
|
Jacquemin J, Drouet Y, Le Guevelou J, Servagi-Vernat S, Thariat J. Modélisation de la survie de patients atteints d’un cancer anaplasique de la thyroïde par régression pénalisée LASSO. Rev Epidemiol Sante Publique 2021. [DOI: 10.1016/j.respe.2021.04.081] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022] Open
|
5
|
Marchand-Crety C, Riverain J, Drouet Y, Felici F, Jeandidier CL, Thariat J, Servagi-Vernat S. A new model outperforming RPA and DS-GPA scores for individualized survival prediction of patients following whole brain irradiation for brain metastasis. Cancer Radiother 2021; 25:447-456. [PMID: 33678525 DOI: 10.1016/j.canrad.2021.02.002] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/30/2020] [Revised: 02/02/2021] [Accepted: 02/03/2021] [Indexed: 11/26/2022]
Abstract
PURPOSE Survival after whole brain radiation therapy (WBRT) in patients with multiple brain metastases (BM) is currently predicted by group-based scoring systems with limited usability for decision. We aimed to develop a more relevant individualized predictive model than Radiation Therapy Oncology Group - Recursive Partitioning Analysis (RTOG-RPA) and Diagnosis - Specific Graded Prognostic Assessment (DS-GPA) for patients with limited life-expectancy. METHODS Based on a Discovery cohort of patients undergoing WBRT, multivariable piecewise Cox regression models with time cut-offs at 1 and 3 months were developed to predict overall survival (OS). A final parsimonious model was defined, and an external validation cohort was used to assess its discrimination and calibration at one, six, and 12 months. RESULTS In the 173-patient Discovery cohort, the majority of patients had primary lung cancer (56%), presence of extracranial disease (ECD) (75%), Eastern Cooperative Oncolgy Group - Performance Status (ECOG-PS) score 1 (41%) and no intracranial hypertension (ICH) (74%). Most patients were classified as the RPA class II (48%). The final piecewise Cox model was based on primary site, age, ECD, ECOG-PS and ICH. An external validation of the model was carried out using a cohort of 79 patients. Individualized survival estimates obtained with this model outperformed the RPA and DS-GPA scores for overall survival prediction at 1-month, 6-months and 12- months in both Discovery and Validation cohorts. A R/Shiny web application was developed to obtain individualized predictions for new patients, providing an easy-to-use tool for clinicians and researchers. CONCLUSION Our model provides individualized estimates of survival for poor prognosis patients undergoing WBRT, outperforming actual scoring systems.
Collapse
Affiliation(s)
- C Marchand-Crety
- Department of Radiation Oncology, Institut Godinot, Reims, France.
| | - J Riverain
- Department of Radiation Oncology, Centre François Baclesse, ARCHADE, Caen, France; Laboratoire de physique corpusculaire IN2P3/ENSICAEN, France
| | - Y Drouet
- Centre Léon Bérard, Département Prévention et Santé Publique, Lyon, France; Université de Lyon, CNRS UMR 5558 LBBE, Villeurbanne, France
| | - F Felici
- Department of Radiation Oncology, Institut Godinot, Reims, France
| | - C L Jeandidier
- Department of Radiation Oncology, Centre Paul Strauss, Unicancer, Strasbourg, France
| | - J Thariat
- Department of Radiation Oncology, Centre François Baclesse, ARCHADE, Caen, France; Laboratoire de physique corpusculaire IN2P3/ENSICAEN, France; UMR6534 Unicaen - Normandie Université, France
| | - S Servagi-Vernat
- Department of Radiation Oncology, Institut Godinot, Reims, France
| |
Collapse
|
6
|
Vandendorpe B, Drouet Y, Ramiandrisoa F, Guilbert P, Costa B, Servagi-Vernat S. Psychological and physical impact in women treated for breast cancer: Need for multidisciplinary surveillance and care provision. Cancer Radiother 2021; 25:330-339. [PMID: 33446421 DOI: 10.1016/j.canrad.2020.12.005] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/29/2020] [Revised: 12/02/2020] [Accepted: 12/12/2020] [Indexed: 12/01/2022]
Abstract
PURPOSE Cancer survivors often experience adverse physical and psychosocial effects. Fear of recurrence is a difficulty very commonly reported in post-cancer life. The primary objective of this study was to describe post-cancer supportive care needs in patients treated for breast cancer. PATIENTS AND METHODS In this monocentric observational study, cancer survivors aged≥18years, diagnosed with breast cancer and treated in 2017 (cohort A) and in 2015 (cohort B) were administered a post-cancer needs questionnaire, and the Fear of Cancer Recurrence Inventory (severity subscale). RESULTS The study included 139 patients. Pain (51.9%), fatigue (51.9%), weight gain during treatment (35.1%), psychological difficulties (20.5%), and difficulties in marriage and sexual life (13.1%) were the complaints in the post-cancer period. There were no differences between the two cohorts. The severity subscale of the Fear of Cancer Recurrence Inventory showed 35.8% patients with a score>13. The fear of recurrence was a source of social difficulties, psychological disorders, and difficulties in marriage and sexual life. CONCLUSIONS Not only FCR, but also issues such as fatigue, pain, psychological difficulties, and difficulties in marriage and sexual life all call for a psycho-oncological follow-up. Clinical and radio-senological surveillance is essential, but it absolutely must be accompanied by a multidisciplinary follow-up, with central importance to psychological care.
Collapse
Affiliation(s)
- B Vandendorpe
- Department of Radiation Oncology, Oscar-Lambret Centre, 3, rue Frédéric-Combemale, 59000 Lille, France; Department of Radiation Oncology, Jean-Godinot Institute, 1, rue du Général-Koenig, 51100 Reims, France.
| | - Y Drouet
- Public Health Department, Léon-Bérard Centre, Lyon, France; CNRS UMR 5558 LBBE, Lyon university, Villeurbanne, France
| | - F Ramiandrisoa
- Department of Radiation Oncology, Jean-Godinot Institute, 1, rue du Général-Koenig, 51100 Reims, France
| | - P Guilbert
- Department of Radiation Oncology, Jean-Godinot Institute, 1, rue du Général-Koenig, 51100 Reims, France
| | - B Costa
- Support Care Department, Godinot Institute, 1, rue du Général-Koenig, 51100 Reims, France
| | - S Servagi-Vernat
- Department of Radiation Oncology, Jean-Godinot Institute, 1, rue du Général-Koenig, 51100 Reims, France
| |
Collapse
|
7
|
Drouet Y, Roulland S, Paolo V, Salles G, Nadel B, Ghesquières H. Prédiction individualisée du risque de lymphome folliculaire à l’aide d’une combinaison de la fréquence t(14;18) mesurée dans le sang des années avant le diagnostic et d’un score de risque polygénique (PRS). Rev Epidemiol Sante Publique 2020. [DOI: 10.1016/j.respe.2020.03.046] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
8
|
Vandendorpe B, Drouet Y, Ramiandrisoa F, Guilbert P, Costa B, Servagi-Vernat S. Évaluation des besoins après le traitement des patientes atteintes d’un cancer du sein. Cancer Radiother 2019. [DOI: 10.1016/j.canrad.2019.07.114] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
9
|
Marchand-Créty C, Riverain J, Drouet Y, Thariat J, Servagi-Vernat S. EP-1620 A model for individualized estimation of survival in patients who underwent whole-brain radiotherapy. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)32040-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022]
|
10
|
Corbin S, Drouet Y, Barone G, Triviaux D, Lasset C. Hospital staff's opinion on a smoke-free policy: A survey at the Léon-Bérard Cancer Center of Lyon, France. Rev Epidemiol Sante Publique 2018. [DOI: 10.1016/j.respe.2018.05.383] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022] Open
|
11
|
Moyret-Lalle C, Drouet Y, Treilleux I, Léon S, Viari A, Devouassoux-Shisheboran M, Voirin N, De la Fouchardiere C, Puisieux A, Lasset C. PO-226 Integrated analysis highlights APC11 protein expression as a likely new independent predictive marker for colorectal cancer. ESMO Open 2018. [DOI: 10.1136/esmoopen-2018-eacr25.743] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022] Open
|
12
|
Drouet Y, Bonadona V, Gargano E, Kardous E, Chauvin H, Girerd-Genessay I, Dussart S, Handallou S, Lasset C. Classification des familles de type sein–ovaire sans mutation constitutionnelle de BRCA1/2 identifiée, pour le niveau de risque de cancer du sein : apport d’une stratégie d’évaluation multicritères s’appuyant sur une méthode d’analyse factorielle. Rev Epidemiol Sante Publique 2017. [DOI: 10.1016/j.respe.2017.04.039] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022] Open
|
13
|
Boyault S, Drouet Y, Lasset C, Navarro C, Puisieux A, Bachelot TD, Wang Q. Frequent and subtype-related genetic mutational signature suggesting the involvement of specific signaling pathway. J Clin Oncol 2010. [DOI: 10.1200/jco.2010.28.15_suppl.e21015] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022] Open
|
14
|
Coulet O, Thiery G, Gal M, Drouet Y, Liard O, Tomasi M. [Extracting a foreign body from the nasal fossa without an ENT specialist]. Med Trop (Mars) 2008; 68:83-86. [PMID: 18478779] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 05/26/2023]
Abstract
Foreign bodies in the nasal fossa are frequent and generally occur in children. In developing countries, access to an ENT specialist can be difficult or impossible. The authors describe several extraction techniques with special emphasis on those best suited to areas with limited access to specialist facilities. Using illustrations, a step-by-step description of the so-called "hook" technique is given. This simple technique allows successful removal of a foreign body from the nasal fossa in almost all cases.
Collapse
Affiliation(s)
- O Coulet
- Service ORL et chirurgie cervico-faciale, Groupe Médico-Chirurgical Bouffard, Djibouti.
| | | | | | | | | | | |
Collapse
|
15
|
Coulet O, Tomasi M, Gal M, De Bruyne S, Drouet Y, Salgas P, Zanaret M. [Venous malformations of the parotid in adults. Report of two cases and review of the literature]. Ann Otolaryngol Chir Cervicofac 2002; 119:356-62. [PMID: 12527846] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/28/2023]
Abstract
Parotid vascular malformation in the adult is a very rare and benign tumor; only 47 cases were described in the world literature. This vascular malformation, mostly of venous origin is, on the opposite of the clinical, histological and evolution features of parotid hemangiomas in children, which are more frequent. Some clinical and radiological elements are pathognomonic allowing preoperative diagnosis. We present 2 cases of intraparotid venous malformation in adults, and based on an exhaustive study of the world literature discuss frequency, diagnosis and treatment of this disease.
Collapse
Affiliation(s)
- O Coulet
- Service d'ORL et Chirurgie Cervico-Faciale, Hôpital d'Instruction des Armées Laveran, 34 Bd Laveran 13013 Marseille.
| | | | | | | | | | | | | |
Collapse
|
16
|
Droy-Lefaix MT, Drouet Y, Geraud G, Hosford D, Braquet P. Superoxide dismutase (SOD) and the PAF-antagonist (BN 52021) reduce small intestinal damage induced by ischemia-reperfusion. Free Radic Res Commun 1991; 12-13 Pt 2:725-35. [PMID: 2060844 DOI: 10.3109/10715769109145852] [Citation(s) in RCA: 63] [Impact Index Per Article: 1.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Abstract
Oxygenated free-radicals appear to play a prominent role in mediating damage associated with gastrointestinal diseases. Production of reactive oxygen metabolites in ischemia-reperfusion involves oxidases found in resident phagocytic cells and microvascular and mucosal epithelial cells. Platelet activating factor (PAF), a phospholipid associated with inflammatory disorders, has been shown to both prime and amplify the release of superoxide anion and hydrogen peroxide from polymorphonuclear neutrophils and macrophages stimulated by FMLP or PMA. To further elucidate the involvement of free radicals in intestinal damage and the potential role of PAF in their production, we examined the effect of superoxide dismutase (SOD) and BN 52021 (ginkgolide B) on ischemia-reperfusion induced damage in the small intestine. The study involved 32 Sprague-Dawley rats (100-200 g) divided into four groups. Three of these groups were subjected to occlusion of the mesenteric artery 30 mins followed by 24 h reperfusion. On 2 groups SOD (15,000 U/kg/iv) and BN 52021 (20 mg/kg/po) were administered 45 mins before arterial occlusion. Following the 24 h reperfusion, the rats were sacrificed after overnight fasting. The jejunum and ileon were removed and fixed for morphological examination. Lesions in the small intestine were quantified. The results showed extensive necrosis, hemorrhage, oedema and neutrophil invasion in the jejunal and ileal mucosa. This injury was significantly reduced by SOD (15,000 U/kg/iv) and BN 52021 (20 mg/kg/po) pretreatment. In conclusion, free-oxygenated radicals appear to mediate reperfusion damage in the small intestine and PAF appears to be involved in the genesis of these toxic products. Thus, SOD and BN 52021 may be considered as protectors against ischemic disorders.
Collapse
|
17
|
Droy-Lefaix MT, Drouet Y, Braquet P, Géraud G. Effect of the platelet-activating factor (PAF) antagonist, BN 52021, on free radical-induced intestinal ischemia-reperfusion damage in the rat. Adv Exp Med Biol 1990; 264:419-22. [PMID: 2244522 DOI: 10.1007/978-1-4684-5730-8_67] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 12/30/2022]
Affiliation(s)
- M T Droy-Lefaix
- I.H.B./IPSEN Research Laboratories, Le Plessis Robinson, France
| | | | | | | |
Collapse
|
18
|
Droy-Lefaix MT, Drouet Y, Geraud G, Braquet P. The amplificative role of PAF-acether in the oxidative stress following reperfusion of ischemic stomach. Basic Life Sci 1988; 49:887-90. [PMID: 3250539 DOI: 10.1007/978-1-4684-5568-7_144] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
19
|
Racadot J, Gremain J, Kujas M, Drouet Y, Olivier L. [Involvement of arterial vessels in the blood supply to adenomas of the human pituitary, functional implications]. Bull Assoc Anat (Nancy) 1986; 70:5-12. [PMID: 2832021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 01/02/2023]
Abstract
Among 190 human pituitary adenomas investigated, 140 contained arterial blood vessels (nearly 75 percent). In 160 adenomas (PRL-, GH-secreting or nonfunctioning tumors) arterial vessels were present in 80 to 90 percent of the cases, whereas in 30 corticotropic adenomas (Cushing's disease), 5 only contained arterial vessels. According to data of the literature and to our own findings, such vessels should originate from the anterior pituitary itself or from the surrounding structures (trabecular, interlobar, capsular arteries). This arterial blood supply could appear even at the microadenoma stage and increase as the tumor growths. Consequently, the blood from portal origin will be diluted or excluded, so that tumor cells would escape from hypothalamic control.
Collapse
Affiliation(s)
- J Racadot
- Laboratoire d'Histologie et Embryologie, Faculté de Médecine, Pitié-Salpêtrière, Paris
| | | | | | | | | |
Collapse
|